You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Zanubrutinib for treating relapsed or refractory mantle cell lymphoma
Technology appraisal guidance
Reference number:
TA1081
Published:
10 July 2025
Guidance
Tools and resources
Information for the public
Evidence
History
Scoping commenced.
Back to top